BioBeats raised €2.6M in a funding round in Aug 2018. The company is based in Pisa, Italy. Investors in the round: IQ Capital, Oxford Sciences Innovation, White Cloud. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
